Shingo Hatakeyama

Associate professor

Hirosaki University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Shingo Hatakeyama is an Associate Professor at Hirosaki University in Japan. His research focuses on the application of machine learning in predicting medical complications, the effects of chemotherapy on cancer treatments, and the safety of robotic surgical procedures. He has published recent articles that investigate various aspects of bladder and prostate cancer, as well as the relationship between health factors and surgical outcomes.

Articles (24)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (4)

Ji Youl Lee

SOUTH KOREA

View details

Naoki Fujita

Assistant Professor

Hirosaki University Graduate School of Medicine

JAPAN

View details

Yasuhiro Sakai

Senior Assistant Professor

Fujita Health University

JAPAN

View details

Teppei Okamoto

Tohoku University Hospital

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shingo Hatakeyama

Research Interests

Explore related searches

Contact this professor

About

Articles (24)

Serum Serotonin Levels as a Potential Risk Factor for Overactive Bladder in a Community‐Dwelling Population: A Four‐Year Longitudinal Study

Machine Learning‐Based Prediction of Life‐Threatening Complications During Hemodialysis in Hospitalized Patients With Poor General Conditions

Annexin A1‐Targeted d‐Peptide‐Monomethyl Auristatin E Conjugate Enhanced Antitumor Effect of Monomethyl Auristatin E for Chemotherapy of Prostate Cancer

Safety of Robot‐Assisted Radical Cystectomy for Muscle‐Invasive Bladder Cancer: A Real‐World Analysis Using the National Clinical Database in Japan

Effects of the Number of Neoadjuvant Cycles and Addition of Adjuvant Chemotherapy on the Prognosis of Muscle‐Invasive Bladder Cancer Treated With Radical Cystectomy

Estimating the Morbidity of Robot-Assisted Radical Cystectomy Using the Comprehensive Complication Index: Data from the Asian Robot-Assisted Radical Cystectomy Consortium

Pre-Op Hydronephrosis Predicts Outcomes in Patients Receiving Robot-Assisted Radical Cystectomy

Treatment trends in patients with de novo metastatic prostate cancer in the era of upfront combination therapy

Associations of remaining teeth number, periodontal disease, and occlusal support status with erectile dysfunction in community‐dwelling men

Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second‐line treatment with tyrosine kinase inhibitor following first‐line immune‐oncology combination therapy

Summary of the Clinical Practice Guidelines for Upper Tract Urothelial Carcinoma 2023 by the Japanese Urological Association

Incidence of postoperative cytomegalovirus and BK-polyoma virus infections and graft loss in ABO-incompatible renal transplant recipients: a multicenter retrospective study

Impact of nephroureterectomy on postoperative renal function in upper tract urothelial carcinoma: A multicenter retrospective study.

Relationship between lower urinary tract symptoms and frailty.

Trends in the age of hospitalized patients with urological cancers: A 17-year experience.

Combination of Muscle Quantity and Quality Is Useful to Assess the Necessity of Surveillance after a 5-Year Cancer-Free Period in Patients Who Undergo Radical Cystectomy: A Multi-Institutional Retrospective Study.

Impact of an optimized surveillance protocol based on the European Association of Urology substratification on surveillance costs in patients with primary high-risk non-muscle-invasive bladder cancer.

Humoral response to SARS-CoV-2 mRNA vaccine on in ABO blood type incompatible kidney transplant recipients treated with low-dose rituximab

Trends in the use of local intervention for metastatic hormone‐naïve prostate cancer: A multicenter retrospective study

Testicular teratomagenesis from primordial germ cells with overexpression of germinal center‐associated nuclear protein

Comparison of neoadjuvant chemohormonal therapy vs. extended pelvic lymph-node dissection in high-risk prostate cancer treated with robot-assisted radical prostatectomy

Impact of timing of rejection episode on cardiovascular events in living donor kidney transplantation: a multicenter retrospective study

The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non‐clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group database

Oncological and functional outcomes of female reproductive organ-sparing radical cystectomy and ileal neobladder construction.

Collaborators (4)

Ji Youl Lee

Naoki Fujita

Yasuhiro Sakai

Teppei Okamoto

Make your next move.